Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Moodys
Mallinckrodt
AstraZeneca
Johnson and Johnson

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Wyeth v. Biovail Corporation (D. Del. 2008)

See Plans and Pricing

« Back to Dashboard

Wyeth v. Biovail Corporation (D. Del. 2008)

Docket   Start Trial Date Filed 2008-06-26
Court District Court, D. Delaware Date Terminated 2010-03-10
Cause 35:271 Patent Infringement Assigned To Joseph James Farnan Jr.
Jury Demand None Referred To
Parties BIOVAIL CORPORATION; BIOVAIL LABORATORIES INTERNATIONAL SRL; BIOVAIL TECHNOLOGIES LTD.; WYETH
Patents 4,138,475; 4,389,393; 4,535,186; 4,966,768; 6,274,171; 6,403,120; 6,419,958
Attorneys Jack B. Blumenfeld; Karen Jacobs; Karen Jacobs Louden; Richard D. Kirk; Stephen B. Brauerman
Link to Docket External link to docket
Small Molecule Drugs cited in Wyeth v. Biovail Corporation
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Wyeth v. Biovail Corporation (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-06-26 1 Complaint (45) Date of Patent: Aug. 14, 2001 (54) EXTENDED RELEASE FORMULA'I`ION OF 4,138,475 * 211979 McAinsh…al. (45) Date of Patent: Jun. 11, 2002 (54) EXTENDED RELEASE FORMULATION OF 4,138,475 A 2/1979 McAinsh…al. (45) Date of Patent: *Jul. 16, 2002 (54) EXTENDED RELEASE FORMULAT[ON OF 4,138,475 A * 2J1979 McAinsh…release rates and blood levels. U.S. Pat. No. 4,138, 475 discloses a sustained release pharmaceutical …release rates and blood leve]s. U.S. Pat. No. 4,138, 475 discloses a sustained release pharmaceutical External link to document
2008-06-27 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,274,171 B1; US 6,403,120 …TRADEMARK 1 US 6,274,171 B1 08/14/01 American … PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK… G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
2010-03-23 43 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,274,171 B1; US 6,403,120 …2008 10 March 2010 1:08-cv-00390 830 Patent None District Court, D. Delaware External link to document
2008-06-27 5 Request for Waiver of Service (45) Date of Patent: Aug. 14, 2001 (54) EXTENDED RELEASE FORMULA'I`ION OF 4,138,475 * 211979 McAinsh…al. (45) Date of Patent: Jun. 11, 2002 (54) EXTENDED RELEASE FORMULATION OF 4,138,475 A 2/1979 McAinsh…al. (45) Date of Patent: *Jul. 16, 2002 (54) EXTENDED RELEASE FORMULAT[ON OF 4,138,475 A * 2J1979 McAinsh…release rates and blood levels. U.S. Pat. No. 4,138, 475 discloses a sustained release pharmaceutical …release rates and blood leve]s. U.S. Pat. No. 4,138, 475 discloses a sustained release pharmaceutical External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Moodys
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.